Literature DB >> 33584683

Age-Related Immunoreactivity Profiles to Diverse Mycobacterial Antigens in BCG-Vaccinated Chinese Population.

Qing-Yuan Yang1, Yu-Tong Zhang1, Jia-Ni Xiao1, Yu-Shuo Liang1, Ping Ji1, Shu-Jun Wang1, Ying Wang1,2, Yingying Chen1.   

Abstract

Long-term immunoreactivity to mycobacterial antigens in Bovis Calmette-Guérin (BCG)-vaccinated population is not well investigated. Herein, 361 volunteer healthy donors (HDs) with neonatal BCG vaccination from Shanghai region (China) were enrolled. They were subdivided into ESAT-6/CFP10- (E6C10-) and ESAT-6/CFP10+ (E6C10+) groups based on gamma-interferon release assays (IGRAs). Three mycobacterial antigens, including Rv0934, Rv3006, and Rv3841, were subjected to the determination of immunoreactivity by ELISPOT assay. The immunoreactivities to three mycobacterial antigens were firstly compared among TB patients (N=39), E6C10+ HDs (N=78, 21.61% of HDs) and E6C10- HDs (N=283, 78.39% of HDs). It was revealed that Rv3006 was dominant upon M.tb infection, while Rv3841 was likely to be more responsive upon latent TB infection. In E6C10- population, the immunoreactivity to Rv3841 maintained along with aging, whereas those to Rv3006 and Rv0934 attenuated in E6C10- HDs older than 45 years old. Our study implies the shift of dominant antigens at different infection statuses, providing the clues for the selection of mycobacterial antigens in vaccine development and precision revaccination in the future.
Copyright © 2021 Yang, Zhang, Xiao, Liang, Ji, Wang, Wang and Chen.

Entities:  

Keywords:  BCG vaccination; aging; healthy population; immunoreactive profiles; mycobacterial proteins

Year:  2021        PMID: 33584683      PMCID: PMC7878369          DOI: 10.3389/fimmu.2020.608220

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  28 in total

1.  The effect of bacille Calmette-Guérin vaccination at birth on immune response in China.

Authors:  Yu Pang; Wanli Kang; Aihua Zhao; Guan Liu; Weixin Du; Miao Xu; Guozhi Wang; Yanlin Zhao; Suhua Zheng
Journal:  Vaccine       Date:  2014-11-06       Impact factor: 3.641

2.  Assessing humoral immune response of 4 recombinant antigens for serodiagnosis of tuberculosis.

Authors:  Paramanandhan Pukazhvanthen; Deenadayalan Anbarasu; Syed Ahamed Kabeer Basirudeen; Alamelu Raja; Mahavir Singh
Journal:  Tuberculosis (Edinb)       Date:  2014-12       Impact factor: 3.131

3.  BCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot Study.

Authors:  Jenneke Leentjens; Matthijs Kox; Robin Stokman; Jelle Gerretsen; Dimitri A Diavatopoulos; Reinout van Crevel; Guus F Rimmelzwaan; Peter Pickkers; Mihai G Netea
Journal:  J Infect Dis       Date:  2015-06-12       Impact factor: 5.226

4.  Disease state differentiation and identification of tuberculosis biomarkers via native antigen array profiling.

Authors:  Mark J Sartain; Richard A Slayden; Krishna K Singh; Suman Laal; John T Belisle
Journal:  Mol Cell Proteomics       Date:  2006-08-09       Impact factor: 5.911

Review 5.  BCG and protection against inflammatory and auto-immune diseases.

Authors:  Magdalena Kowalewicz-Kulbat; Camille Locht
Journal:  Expert Rev Vaccines       Date:  2017-05-30       Impact factor: 5.217

6.  Identification, isolation and partial characterization of Mycobacterium tuberculosis glycoprotein antigens.

Authors:  C Espitia; R Mancilla
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

7.  Use of multiepitope polyproteins in serodiagnosis of active tuberculosis.

Authors:  Raymond L Houghton; Michael J Lodes; Davin C Dillon; Lisa D Reynolds; Craig H Day; Patricia D McNeill; Ronald C Hendrickson; Yasir A W Skeiky; Diana P Sampaio; Roberto Badaro; Konstantin P Lyashchenko; Steven G Reed
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

8.  Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose.

Authors:  Claus Aagaard; Truc Thi Kim Thanh Hoang; Angelo Izzo; Rolf Billeskov; JoLynn Troudt; Kim Arnett; Andrew Keyser; Tara Elvang; Peter Andersen; Jes Dietrich
Journal:  PLoS One       Date:  2009-06-16       Impact factor: 3.240

9.  Mycobacterial Lipoprotein Z Triggers Efficient Innate and Adaptive Immunity for Protection Against Mycobacterium tuberculosis Infection.

Authors:  Yingying Chen; Jia-Ni Xiao; Yong Li; Yang-Jiong Xiao; Yan-Qing Xiong; Ying Liu; Shu-Jun Wang; Ping Ji; Guo-Ping Zhao; Hao Shen; Shui-Hua Lu; Xiao-Yong Fan; Ying Wang
Journal:  Front Immunol       Date:  2019-01-16       Impact factor: 7.561

10.  Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study.

Authors:  Patrick Nguipdop-Djomo; Einar Heldal; Laura Cunha Rodrigues; Ibrahim Abubakar; Punam Mangtani
Journal:  Lancet Infect Dis       Date:  2015-11-19       Impact factor: 25.071

View more
  1 in total

1.  Display of receptor-binding domain of SARS-CoV-2 Spike protein variants on the Saccharomyces cerevisiae cell surface.

Authors:  Hongguan Xing; Liyan Zhu; Pingping Wang; Guoping Zhao; Zhihua Zhou; Yi Yang; Hong Zou; Xing Yan
Journal:  Front Immunol       Date:  2022-08-12       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.